SLS
Sellas Life Sciences Group Inc
11.60$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Sellas Life Sciences Group Inc (SLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.1 | -6.0 | -9.4 | -12 | -10 | -15 | -21 | -29 | -43 | -48 | -45 | -11 | -30 | -18 | -10 | -26 | -24 | -31 | -35 | -28 | |
| – | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | 0.5 | 0.9 | 0.4 | 0.1 | 0.0 | 3.8 | 1.7 | 0.3 | 5.7 | 0.5 | – | – | – | |
| – | – | 3.8 | 4.2 | 4.4 | 3.0 | 1.4 | 2.5 | 5.4 | 1.9 | 2.3 | 3.2 | 0.4 | 0.6 | 0.6 | 1.0 | 1.7 | 1.4 | 1.6 | 2.0 | |
| – | – | – | – | – | 3.1 | 0.7 | -0.1 | 5.6 | -7.1 | -9.2 | 6.4 | 7.5 | 3.3 | 0.8 | 2.3 | 12 | – | – | – | |
| -0.2 | 0.7 | 0.0 | 0.3 | 0.3 | 2.6 | 0.1 | 2.5 | 4.0 | 20 | -25 | 6.1 | -10 | -1.1 | 5.6 | -7.6 | 5.6 | 3.3 | -6.6 | -4.1 | |
| 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.7 | 16 | 5.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.5 | 5.5 | 0.0 | 0.0 | |
| – | -10 | 9.6 | -0.1 | -0.1 | 0.0 | -0.1 | -12 | -5.5 | 10 | -1.1 | 1.8 | – | -4.5 | -4.5 | -4.5 | -4.5 | -5.5 | – | – | |
| – | – | – | – | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.7 | 0.5 | 0.0 | – | – | – | – | – | – | |
| – | – | – | – | -3.8 | 19 | 42 | 46 | 26 | 47 | 34 | 0.5 | 31 | 20 | 38 | – | – | 0.0 | – | – | |
| – | – | – | – | – | -0.1 | 0.0 | 9.8 | -1.8 | -3.9 | 18 | -0.5 | -7.6 | – | – | – | – | – | – | – | |
| 2.1 | 18 | 7.9 | 7.7 | 12 | 19 | 42 | 56 | 24 | 44 | 34 | 5.5 | 23 | 20 | 38 | 12 | 24 | 22 | 47 | 86 | |
| 2.1 | 1.8 | 8.1 | -4.2 | 1.2 | 4.5 | 21 | 15 | -24 | 6.1 | -12 | -3.6 | -7.3 | 1.9 | 28 | -14 | -4.2 | -15 | 11 | 58 | |
| -2.1 | -6.3 | -9.6 | -12 | -10 | -15 | -21 | -45 | -48 | -48 | -45 | -11 | -30 | -18 | -10 | -26 | -28 | -37 | -35 | -28 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.